Abstract
This report analyzes the worldwide markets for Specialty Enzymes in Millions
of US$. The specific product segments analyzed are Specialty Medical Enzymes,
Polymerases, Nucleases, and Other Specialty Enzymes. The specific end-use
segments discussed are Pharmaceuticals & Diagnostics, and
Research/Biotechnology. The report provides separate comprehensive analytics
for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin
America. Annual forecasts are provided for each region for the period of 2000
through 2015. The report profiles 44 companies including many key and niche
players worldwide such as Advanced Enzymes Technologies Limited, Amano Enzyme
Inc., Aureozyme Inc., Biocon Ltd., Operational Model of Biocon, Biozyme
Laboratories, Danisco, Genencor, Kinetic Biosystems, Inc., Maxygen Inc,
Codexis Inc., Novozymes, Seravac Biotech (Pty) Ltd, Specialty Enzymes and
Biochemicals Co., and Verenium Corporation. Market data and analytics are
derived from primary and secondary research. Company profiles are mostly
extracted from URL research and reported select online sources.